JP2018517722A5 - - Google Patents

Download PDF

Info

Publication number
JP2018517722A5
JP2018517722A5 JP2017564597A JP2017564597A JP2018517722A5 JP 2018517722 A5 JP2018517722 A5 JP 2018517722A5 JP 2017564597 A JP2017564597 A JP 2017564597A JP 2017564597 A JP2017564597 A JP 2017564597A JP 2018517722 A5 JP2018517722 A5 JP 2018517722A5
Authority
JP
Japan
Prior art keywords
hrv
composition
virus
subject
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017564597A
Other languages
English (en)
Japanese (ja)
Other versions
JP6902195B2 (ja
JP2018517722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/037658 external-priority patent/WO2016205389A1/en
Publication of JP2018517722A publication Critical patent/JP2018517722A/ja
Publication of JP2018517722A5 publication Critical patent/JP2018517722A5/ja
Priority to JP2021088164A priority Critical patent/JP2021152024A/ja
Application granted granted Critical
Publication of JP6902195B2 publication Critical patent/JP6902195B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017564597A 2015-06-15 2016-06-15 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用 Active JP6902195B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021088164A JP2021152024A (ja) 2015-06-15 2021-05-26 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562175832P 2015-06-15 2015-06-15
US62/175,832 2015-06-15
PCT/US2016/037658 WO2016205389A1 (en) 2015-06-15 2016-06-15 Multivalent enterovirus vaccine compositions and uses related thereto

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021088164A Division JP2021152024A (ja) 2015-06-15 2021-05-26 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用

Publications (3)

Publication Number Publication Date
JP2018517722A JP2018517722A (ja) 2018-07-05
JP2018517722A5 true JP2018517722A5 (enExample) 2019-07-18
JP6902195B2 JP6902195B2 (ja) 2021-07-14

Family

ID=57546427

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017564597A Active JP6902195B2 (ja) 2015-06-15 2016-06-15 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用
JP2021088164A Pending JP2021152024A (ja) 2015-06-15 2021-05-26 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021088164A Pending JP2021152024A (ja) 2015-06-15 2021-05-26 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用

Country Status (7)

Country Link
US (1) US11160857B2 (enExample)
EP (1) EP3307311A4 (enExample)
JP (2) JP6902195B2 (enExample)
KR (1) KR20180086180A (enExample)
CN (1) CN108025055B (enExample)
CA (1) CA2989332A1 (enExample)
WO (1) WO2016205389A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160857B2 (en) * 2015-06-15 2021-11-02 Emory University Multivalent enterovirus vaccine compositions and uses related thereto
CN109337876A (zh) * 2018-10-15 2019-02-15 北京世纪元亨动物防疫技术有限公司 一种猪流行性腹泻病毒的纯化方法
JP2022521410A (ja) * 2019-02-21 2022-04-07 センティヴァックス， インコーポレイテッド 最適化されたワクチン組成物およびその製造方法
CN115869324B (zh) * 2022-12-30 2024-02-27 湖北工业大学 Efavirenz在制备抗肠道病毒药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946676A (en) 1986-08-27 1990-08-07 De Staat Der Nederlanden Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
US5714374A (en) 1990-09-12 1998-02-03 Rutgers University Chimeric rhinoviruses
US20020086386A1 (en) 1997-03-04 2002-07-04 Kamb Carl Alexander B-catenin assays, and compositions therefrom
US20060088549A1 (en) 2004-07-08 2006-04-27 Arnold Gail F Chimeric virus vaccine
US8153760B2 (en) 2005-01-19 2012-04-10 Donald Danforth Plant Science Center Rhinovirus vaccines
EP2066343B1 (en) * 2006-09-29 2017-06-14 Sanofi Pasteur Biologics, LLC Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
US20110091501A1 (en) 2008-03-27 2011-04-21 Sanofi Pasteur Biologics Co. Recombinant Rhinovirus Vectors
EP2414520A2 (en) * 2009-03-31 2012-02-08 Altair Therapeutics, Inc. Methods of modulating an immune response to a viral infection
US20110293700A1 (en) * 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
EP2765137A1 (en) 2013-02-07 2014-08-13 Sanofi Pasteur Induction of cross-reactive cellular response against rhinovirus antigens
BR112015031541A2 (pt) * 2013-06-17 2017-07-25 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport métodos para o impedimento da agregação de componentes virais
WO2015179979A1 (en) 2014-05-28 2015-12-03 National Health Research Institutes Viral particles as immunogens against enterovirus infection and production thereof
US11160857B2 (en) * 2015-06-15 2021-11-02 Emory University Multivalent enterovirus vaccine compositions and uses related thereto

Similar Documents

Publication Publication Date Title
JP2018517722A5 (enExample)
JP7063957B2 (ja) エンテロウイルス不活化およびアジュバント吸着のための改良された方法、ならびに、それから得られる投与量減量ワクチン組成物
JP2013537518A5 (enExample)
Rajão et al. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs
CN104278009A (zh) 无血清培养基及其用途和一种猪瘟病毒的培养方法
ES2689150T3 (es) Métodos para la prevención de agregación de componentes víricos
Xu et al. Detection of viral components in exosomes derived from NDV-infected DF-1 cells and their promoting ability in virus replication
Abbo et al. Comparative efficacy of Mayaro virus-like particle vaccines produced in insect or mammalian cells
JP2016528176A5 (enExample)
JP2019506134A5 (enExample)
JP2016534062A5 (enExample)
CU24682B1 (es) Una composición de vacuna multivalente compuesta por una mezcla de antígenos provenientes de virus de polio y rotavirus inactivados
RU2603003C1 (ru) Вакцина инактивированная сорбированная против ящура типов а, о, азия-1
Ruan et al. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice
CN106635895B (zh) 一种绵羊肺炎支原体低血清高效培养基及其制备方法
Xu et al. Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5
JP2023091085A (ja) 粘膜アジュバント
CN101642454A (zh) 黄连素在治疗乙肝病毒感染药物中的应用
TWI747866B (zh) 藉由去脂質化使病原體不活化
JP6335399B1 (ja) リアソータントインフルエンザウイルス作出方法
McVernon et al. Absence of cross‐reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months–9 years: a prospective study
Pyeon et al. Setting time properties of cement matrix according to photosynthetic bacterial dilution ratio
RU2018126322A (ru) Термически стабильные ротавирусные вакцинные композиции и способы их применения
CN106729684B (zh) 胸膜肺炎放线杆菌菌影疫苗
TW201722478A (zh) 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法